I
schemic heart disease induces a heterogeneous remodeling response across the damaged area that involves fibroblast activation, cardiomyocyte hypertrophy, and changes in calcium handling, all of which are eventually detrimental for cardiac function.
1,2 Fibroblast activation and cardiomyocyte hypertrophy occur as a direct effect of the local stress signals caused by the loss of viable tissue in the infarcted area. Subsequently, a decline in contractility of the surviving cardiomyocytes occurs, caused by a change in metabolism and calciumhandling genes. 3 Genome-wide transcriptome analysis on extracts from diseased tissues has significantly enhanced our understanding of the gene regulatory networks that drive these pathological changes in the heart. 4, 5 However, to date, these approaches have been disadvantaged by the fact that the signals are derived from tissue homogenates, which inherently causes the loss of spatial information and dilutes out more localized expression signatures. Recent developments in RNA amplification strategies provide the opportunity to use small amounts of input RNA for genome-wide sequencing. Here we use tomo-seq 6 to obtain a genome-wide gene expression signature with high spatial resolution spanning from the infarcted area to the remote. Tracing transcriptional differences across the infarcted heart enabled us to identify clusters of genes with a comparable gene expression profile. In these individual clusters, we recognized genes with well-known functions in specific aspects of heart remodeling, such as Col1a2 for fibrosis, Nppa for cardiomyocyte hypertrophy, or Serca2 for contractility. Correlation analyses using the spatial distribution patterns of these marker genes allowed for the identification of novel factors that share a comparable transcriptional regulation pattern across the infarcted tissue. Subsequent functional annotation analysis indicated that these genes could be linked to the known gene function of their reference gene. The strong correlation between the expression levels of the marker genes and the expression of the coregulated genes could be confirmed in human ischemic tissue samples.
Our data show that the high spatial resolution in gene expression signatures obtained by tomo-seq reveals new regulators, genetic pathways, and transcription factors that are active in well-defined regions of the heart and potentially involved in specific aspects of heart disease. Using this technique, we identified SOX9 as a potent regulator of many of the Col1a2 coregulated genes. In vivo loss of Sox9 reduced the expression of many extracellular matrix (ECM) genes, which coincided with a blunted cardiac fibrotic response on ischemic injury. These data unveil the currently unknown relevance of SOX9 as a key regulator of cardiac fibrosis and underscores that tomo-seq can be used to increase our mechanistic insights into cardiac remodeling to help guide the identification of novel therapeutic candidates.
METHODS
An expanded Methods section is available in the online-only Data Supplement. All reported gene expression data are available in the online-only Data Supplement.
Ischemia Reperfusion Model
Animal experiments were performed in accordance with the institutional review committee at the Hubrecht Institute. Mice were randomly subjected to either sham or ischemia reperfusion surgery as previously described. 7 Two weeks after surgery, cardiac tissues were collected for further analysis.
Tomo-Seq
Tomo-seq experiments were performed as described elsewhere. 6 In short, 2.5-mm-wide portions of cardiac mouse tissue spanning from the infarct toward the remote region of the left ventricular anterior wall were embedded in tissue-freezing medium, frozen on dry ice, and cryosectioned into 48 slices of 80 μm thickness. We extracted RNA from individual slices and prepared barcoded Illumina sequencing libraries according to the CEL-seq protocol. 8 Paired-end reads obtained by Illumina sequencing were aligned to the transcriptome using Burrows-Wheeler Aligner's SmithWaterman alignment. 9 The 5' mate of each pair was used for mapping, discarding all reads that mapped equally well to multiple loci. The 3' mate was used for barcode information. Reads counts were normalized to the same number of total reads per section. Tomo-seq data analysis was performed in MATLAB (MathWorks) using custom-written code. For data analysis, we used an expression cutoff of >4 reads in >1 section. In differential expression analysis ( Figure 1C) , we determined the boundary between remote and infarcted zone based on the spatial partitioning detected by pairwise
Clinical Perspective
What Is New?
• SOX9 is a key regulator of cardiac fibrosis after ischemic injury in mice by regulating the expression of many extracellular matrix-related proteins.
• SOX9 is induced in cardiac tissue from patients suffering from ischemic heart disease and colocalizes with COL1 expression.
• Reduced levels of SOX9 lead to less cardiac fibrosis after ischemic injury in mice.
• Tomo-seq can be used to identify new players in cardiac biology and disease.
What Are the Clinical Implications?
• Our data suggest that therapeutic inhibition of SOX9 in the diseased heart could lead to a reduction in cardiac fibrosis. Nppa co-regulated genes comparison of sections across all genes in 1 biological replicate ( Figure 1B ). For the infarcted zone, we used sections 1 to 26, and for the remote zone we used sections 29 to 47. The border zone (sections 27-29) was omitted to reduce ambiguity in assignment of sections to zones. We then compared the sections within and outside the infarcted zone and assessed statistical significance with Wilcoxon rank sum test. For this analysis, each section was considered as an independent measurement. Furthermore, filtering was applied for genes that showed a ≥2-fold expression difference between the remote and infarcted zones. For this analysis, the mean expression levels for each gene in the two zones were calculated. Concerning the hierarchical clustering, expression traces of the genes that passed the differential expression filter in Figure 1C were used for analysis. The data were standardized by Z-score normalization (along rows of data) so that the mean expression is 0 and the standard deviation is 1 to remove differences in the expression level between genes. Euclidean distance was used as a distance metric. The assignment of genes to clusters I through III ( Figure 1D ) was determined manually considering the similarity in gene expression pattern across the ischemic heart. 
SOX9 Animal Models

Pathway and Transcription Factor Binding Site Enrichment
To investigate whether genes share a similar biological function, we searched for overrepresentation in the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway using DAVID (Database for Annotation, Visualization and Integrated Discovery). 12 The enriched genes in the KEGG pathway are shown as P values corrected for multiple hypothesis testing using the Benjamini-Hochberg method.
Detection of overrepresented conserved transcription factor binding sites in the set of genes spatially coregulated to Col1a2 was determined using single-site analysis in oPOSSUM 3.0 (online software). The enrichment of SOX9 binding sites Figure 1 Continued. C, Pairwise correlation for all sections across genes exhibiting ≥2-fold and statistically significant differential expression between the infarct and remote zones 14 dpIR. D, Hierarchical clustering of expression traces for all genes that were found to be differentially expressed in C. E, Spatial expression pattern of 3 reference genes Col1a2, Nppa, and Serca2 in the hearts from Sham, 1 dpIR, and 14 dpIR mice. 
Genes that contain a predicted/validated SOX9 binding site in their promoter region are marked. ORIGINAL RESEARCH ARTICLE was determined using the Z-score, which uses the normal approximation to the binomial distribution to compare the occurrence rate of a transcription factor binding site in the set of target genes to the expected rate estimated from the precomputed background set.
Human Heart Samples
Approval for studies on human tissue samples was obtained from the Medical Ethics Committee of the University Medical Center Utrecht, The Netherlands (12#387). Written informed consent was obtained or in certain cases waived by the ethics committee when obtaining informed consent was not possible because of patient death. In this study, we included tissue from the left ventricular free wall of patients with end-stage heart failure secondary to ischemic heart disease. This end-stage heart failure tissue was obtained at explanation of the failing heart during heart transplantation or autopsy. For each case, 3 areas of the infarcted heart tissue were included: (1) infarct zone, (2) border zone, and (3) remote area. For in situ hybridization (ISH) analysis, 3 patients were included. From these patients, the border zone of the infarcted hearts was used for ISH to verify tomo-seq. Gene expression values in infarct zone, border zone, and remote area obtained by real-time polymerase chain reaction (PCR) were plotted for correlation analysis. Left ventricular free wall of nonfailing donor hearts that could not be transplanted for technical reasons were used for comparison. In these cases, neither donor patient histories nor echocardiography revealed signs of heart disease.
Statistical Analysis
Values are presented as mean±standard error of the mean. Previous studies were used to predetermine sample size. Statistical analyses between 2 groups were conducted using the 2-tailed unpaired or paired Student t test or a Mann-Whitney test when the normality assumption was not met. Comparison among >2 groups was performed using a 2-way analysis of variance with Bonferroni's post hoc test. Pearson's correlation coefficients were used to calculate gene pair correlation based on gene expression in human samples. KEGG pathways are ranked by their respective P value corrected for multiple hypotheses testing using the Benjamini-Hochberg method. P value <0.05 was interpreted to denote statistical significance. Prism 6 (GraphPad Software, Inc.) was used for statistical analyses.
RESULTS
Tomo-Seq Performed on the Infarcted Mouse Heart
To obtain precise spatial information on local gene expression changes occurring in the heart in response to ischemic injury, we collected cardiac tissue from infarcted mice exposed to 1 hour of ischemia, followed by either 1 or 14 days of ischemia reperfusion (1 and 14 dpIR) and harvested tissues from sham-operated mice as control (Sham) ( Figure 1A and Figure  I in the online-only Data Supplement). 7 Histological and molecular analysis confirmed a classical cardiac remodeling response in our model of ischemic injury, as exemplified by cardiac hypertrophy (hematoxylin and eosin staining), fibrosis (Sirius Red staining), and a change in expression of cardiac markers ( Figure I in the online-only Data Supplement). 7 Using microdissection, a small portion of the anterior wall of the left ventricle spanning from the infarct toward the remote (2.5 mm wide and 4.0 mm long) was processed into ≈50 consecutive cryosections with a thickness of 80 μm ( Figure 1A ). Subsequent RNA extraction from individual slices, followed by RNA amplification, barcoding strategies, and RNA sequencing, 6 provided genomewide data about the spatial distribution in gene expression across the injured heart (Databases I through III in the online-only Data Supplement). A spatial partitioning between infarcted and remote area was visible at 1 and 14 dpIR but not in the sham-operated samples when performing pairwise comparison of sections across all expressed genes ( Figure 1B and Figure  II in the online-only Data Supplement). The spatial separation became considerably more pronounced after filtering for genes that showed a ≥2-fold and statistically significant differential expression between the infarct and remote zone by tomo-seq ( Figure 1C and Figure IIB in the online-only Data Supplement). The number of regulated genes was found to be the highest 14 dpIR, which included 2357 coding genes and 134 noncoding transcripts ( Figure 1D and Figure IIC and Databases IV through VI in the online-only Data Supplement. KEGG analysis on these regulated genes showed enrichment for inflammatory pathway activation at day 1 after injury, whereas pathways involved in ECM, disease, and cardiomyocyte remodeling were found to be regulated 14 dpIR (Figure IID and Tables I  and II in 
Gene Expression Patterns Reveal Localized Remodeling Responses
Tracing transcriptional differences across the infarcted heart enabled us to identify clusters of genes with a ORIGINAL RESEARCH ARTICLE comparable differential regulation throughout the infarcted heart at 14 dpIR ( Figure 1D ). The individual clusters contained well-known marker genes for specific aspects of heart remodeling, Collagen type I alpha 2 (Col1a2) (identified in cluster I), Natriuretic peptide A (Nppa) (identified in cluster II), and sarco-and endoplasmic reticulum Ca 2+ -ATPase (Serca2) (located in cluster III). Col1a2 is expressed in activated fibroblasts and important for cardiac fibrosis, 13 whereas Nppa is a cardiomyocyte-specific stress marker involved in myocyte hypertrophy.
14 Cardiomyocyte contractility is regulated by calcium fluxes to and from the sarcoplasmic reticulum and is impaired during heart disease. Serca2 is a key regulator of Ca 2+ transfer into the sarcoplasmic reticulum in muscle cells that is decreased during heart failure, which contributes to the decline in function. 3 The expression traces for Col1a2, Nppa, and Serca2 confirmed a gene-specific differential regulation from the infarcted area to the remote ( Figure 1E ). As expected, Col1a2 and Nppa were more abundantly expressed in the infarcted region 14 dpIR, whereas Serca2 actually showed a decrease in expression toward the infarcted region ( Figure 1E ). ISH on cardiac tissue 14 dpIR confirmed the Col1a2 expression to originate from activated fibroblasts, whereas the transcriptional peaks for Nppa stemmed from the stressed, hypertrophic cardiomyocytes immediately flanking the fibrotic regions ( Figure 1F ). We observed a decline in Serca2 expression more toward the injured area, which is likely because of both a loss in cardiomyocytes and a decrease in transcriptional activation because the Nppa signals clearly indicate the presence of viable myocytes in this region ( Figure 1F ). The reproducibility of the obtained gene expression profiles was confirmed on a second set of samples ( Figure III in the online-only Data Supplement).
Tomo-Seq Identifies Potential New Players for Cardiac Remodeling and Function
An important advantage of tomo-seq over genome-wide sequencing techniques on tissue homogenates is that the local information on gene regulation allows for correlation analysis to identify genes with a comparable spatial distribution in transcriptional regulation. 6 Because we observed a gene-specific expression profile throughout the infarcted tissue for Col1a2, Nppa, and Serca2, we used the Euclidean distance of Z-score-transformed spatial expression traces 6 to measure pattern similarity between genes 14 dpIR using Col1a2, Nppa, and Serca2 as reference genes. In doing so, we obtained a gene list that showed the greatest similarity in expressional differences across the infarcted tissue with our reference genes (Table, Figure 1G , and Databases VII and VIII in the online-only Data Supplement), a majority of which could be identified within the corresponding gene cluster identified in Figure 1D . It is interesting to note that next to Col1a2, Nppa, and Serca2, these lists also contained other well-known genes related to the biological function of the reference genes. Among the Col1a2 coexpressed genes, we recognized additional genes known for their function in ECM deposition (eg, Sparc and Col3a1), 2 whereas many of the genes coregulated with Nppa encode for proteins involved in cardiomyocyte hypertrophy (Nppb and Myh7). The gene list for Serca2 contained Pln and Ryr2, both well known for their importance in cardiac calcium handling and contractility (Table and Databases VII and VIII in the online-only Data Supplement). 3 This coexpression of genes could be confirmed by ISH and indicated the signals to stem from the same cell population ( Figure 1H ). The connection between the spatially coregulated genes and their biological function was underscored by KEGG pathway analysis. The 150 genes with the highest similarity in expressional changes with either Col1a2, Nppa, or Serca2 throughout the infarcted heart at 14 dpIR indicated enrichment for the cellular function known to be associated with the reference genes ( Figure 1I through 1K and Tables III through V and Databases VII and VIII in the online-only Data Supplement). The known biological link of several of the listed genes and the functional connection based on gene ontology analysis suggest that the correlation analysis can serve to identify genes that are functionally related to the biological function of the reference genes.
RNA sequencing on whole-tissue homogenates from the infarcted area from 3 independent mice 14 dpIR showed a comparable directional regulation in gene expression, with the Col1a2-and Nppa-related genes going up after infarct, whereas the Serca2-related genes are going down compared with sham-operated mice ( Figure IV in the online-only Data Supplement). However, in contrast with the data obtained by tomoseq, the changes observed by RNA sequencing on tissue homogenates failed to provide spatial information on coexpression of genes and showed smaller changes with a high interanimal variation ( Figure IV in the online-only Data Supplement). Because tomo-seq analysis is based on the correlation in gene expression within a single sample, the variation among animals is of lesser importance. Tomo-seq analysis for lncRNAs specifically showed localized expression changes, albeit far less pronounced and specific than for coding genes ( Figure V in the online-only Data Supplement), which is likely because of the low abundance of lncRNA transcripts.
The Correlation in Expression of Novel Genes Linked to Cardiac Remodeling and Function Is Conserved in Humans
Although multiple well-known markers of fibrosis, hypertrophy, and calcium handling could be identified among the genes with a similar transcriptional activation pattern, we also found multiple ill-studied genes that so far have not been linked to aspects of cardiac remodeling (Databases VII and VIII in the online-only Data Supplement). To confirm the correlation in transcriptional activation, we randomly chose 1 candidate from each list to explore in more detail. The Z-score-transformed expression traces at 14 dpIR indicated a close correlation in expressional regulation among Col1a2 with Fstl1, Nppa with Pmepa1, and Serca2 with Chchd2 (Figure 2A) , which could be confirmed by ISH on murine cardiac tissue 14 dpIR ( Figure 2B ). Further confirmation for a correlation in expression of these novel factors with COL1A2, NPPA, and SERCA2 was obtained by ISH on ischemic human heart tissues ( Figure 2C ).
The validity of using tomo-seq to identify genes that are expressionally linked was strengthened by the observation that real-time PCR analysis on cardiac tissue from patients suffering from ischemic heart disease confirmed the correlation between the expression levels of COL1A2, NPPA, SERCA2, and the newly identified genes ( Figure 2D through 2F) . The correlation was strongly reduced when we cross-referenced genes from different lists ( Figure VI in the online-only Data Supplement). The density plot for the cumulative Pearson correlation coefficients validates the shift toward a higher correlation among genes that belong to the same list (coregulated) compared with genes that were not shown to be coregulated (randomized) by tomoseq ( Figure 2G) . It remains to be determined which of the newly defined genes are relevant for cardiac remodeling. Yet the functional link between the coregulated genes and the fact that we can validate the coregulation in both mice and human implies that tomo-seq allows for the identification of novel genes that are potentially relevant for specific aspects of pathological remodeling of the infarcted heart.
Tomo-Seq Identifies SOX9 as a Key Transcription Factor for Cardiac Fibrosis
The overlap in differential expression throughout the infarcted heart triggered us to explore whether a common transcription factor could be responsible for the synchrony in transcriptional regulation of the different gene clusters. Using an in silico approach, we searched for transcription factors (using oPOSSUM 3.0) that contain ≥1 predicted binding site(s) in the promoter regions of the top 30 Col1a2 coregulated genes (Table and  Table VI in the online-only Data Supplement). Among these factors, we identified SOX9 as a potential candidate. SOX9 is a transcription factor recognized for its role in chondrocyte differentiation. 10 Although so far unstudied in the adult heart, previous work showed that SOX9 has a potent function in fibrosis. 15 Expression trace analysis for Sox9 revealed a strong spatial correlation with Col1a2 ( Figure 3A) . ISH indicated Sox9 to be expressed in the same region of the infarcted area as Col1a2 although at a much lower level ( Figure 3B ). Real-time PCR on tissues from infarcted mouse heart further confirmed Sox9 upregulation in the infarct zone ( Figure 3C ). Based on the predicted binding site(s) in the promoter regions of multiple Col1a2 coregulated genes, its proposed function in liver fibrosis, and the overlap in transcriptional regulation with Col1a2 in the infarcted heart, we decided to further pursue SOX9 in cardiac fibrosis. The induction in Sox9 expression was only observed 14 dpIR and restricted to the infarcted area ( Figure VIIA and VIIB in the online-only Data Supplement). Staining for both SOX9 and COL1 indicated SOX9 protein to be detectable in the same region as COL1 ( Figure 3D ).
To start exploring the fate of SOX9-expressing cells in the infarcted heart, we used a lineage-tracing approach using a TdTomato reporter mouse model driven by the promoter of the Sox9 gene (Sox9
CreERT2
;R26R
TdT ) (Figure 3E) . Fluorescence-activated cell sorting performed Figure 4 Continued. healthy control hearts (n=3-10; *P<0.05). C, Validation of the coexpression pattern of SOX9/COL1A2 by in situ hybridization in human ischemic cardiac tissue. Scale bars, 100 μm (left) and 50 μm (right). D and E, Coimmunostaining against SOX9 and α-actinin-2 (ACTN2) (D) or COL1 (E) in the hearts of control individuals or patients suffering from ischemic heart disease (IHD). White arrows point to cells expressing SOX9. Scale bars, 50 μm. on single cells isolated from the left ventricle indicated a significant elevation of the SOX9-TdT + cell population 14 dpIR compared with Sham ( Figure 3F ). Immunostaining clearly showed a colocalization between SOX9-TdT + -and COL1-expressing cells, which were surrounded by cardiomyocytes (marked by α-actinin-2) ( Figure 3G and 3H) . A similar overlap in expression was observed between SOX9-TdT + and cells labeled with 2 other fibroblast markers: periostin and vimentin ( Figure  VIIIA and VIIIB in the online-only Data Supplement, respectively). 16, 17 These data demonstrated that SOX9 is predominantly active in the fibroblast population that repopulates the infarcted area after injury.
To further explore whether SOX9 is involved in the transcriptional activation of the Col1a2-coregulated genes, we treated fibroblasts with transforming growth factor β1 after we exposed them to either an siRNA against Sox9 or a control. In addition to a strong repressive effect on Sox9 expression, we also observed a significant repressive effect on 6 out of 15 potential SOX9 targets listed as Col1a2-coregulated genes, with a general downward trend for the remaining genes ( Figure  VIIC in the online-only Data Supplement). This was also true for additional fibrosis-related genes ( Figure VIID in the online-only Data Supplement), indicating a global function for SOX9 in fibroblast activation.
Real-time PCR analysis in tissue samples from human ischemic hearts showed a significant correlation between the levels of expression of COL1A2 and SOX9 ( Figure 4A ). In agreement with our mouse data, realtime PCR indicated an expressional increase in SOX9 expression toward the infarcted area ( Figure 4B ), where the majority of the fibrosis is located. ISH showed that a subpopulation of COL1A2-positive cells was also positive for SOX9 in human ischemic hearts ( Figure 4C ). Immunostaining further confirmed that SOX9-expressing cells were also positive for COL1 ( Figure 4D and 4E).
SOX9 Regulates Cardiac Fibrosis During Ischemia Reperfusion Injury
To examine the effect of SOX9 in vivo, we generated inducible Sox9 heterozygous knockout mice (Sox9
) ( Figure 5A ). Tamoxifen injection at the day of surgery and 2 and 4 days after injury resulted in a disruption of the Sox9 allele as confirmed by PCR on genomic DNA ( Figure 5B ) and further quantified by real-time PCR and immunofluorescence after IR in the infarcted region ( Figure 5C through 5E). Sox9 loss of function was accompanied with a profound reduction in fibrosis, which was quantified by the amount of Sirius Red staining in the infarcted region ( Figure 5F and 5G). Periostin, a protein marking activated fibroblasts, 17 was also reduced in the infarcted Sox9 fl/+ ;R26 CreERT2 mice treated with Tamoxifen, further confirming the importance of SOX9 as a key driver for fibrosis in the ischemic heart ( Figure 5H ). Expression analysis for 15 randomly selected Col1a2-coexpressed genes showed an increase in expression in response to ischemic injury. Loss of Sox9 resulted in a significant reduction in expression for 13 out of 15 genes 14 dpIR compared with control animals ( Figure 5I and Database VII in the online-only Data Supplement, highlighted in yellow).
High expression levels of SOX9 have previously been described in chondrocytes, and publically available SOX9 ChIP-seq data in this cell type 18 showed that 15 out of the 30 genes that were coexpressed with Col1a2 in our study have ≥1 of their predicted binding sites directly occupied by SOX9 (eg, Col1a2, Fn1, Lum, and Vim; Table and Figure IX in the online-only Data Supplement). It is important to note that these sites were found enriched for the histone mark H3K27ac in the adult mouse heart (ENCODE dataset), which further demonstrates that these regions are active and open for transcription factors such as SOX9 in vivo. Altogether these data demonstrate that SOX9 has the ability to occupy the promoter region of ECM-related genes and may actively regulate these genes in the heart.
DISCUSSION
Here we applied tomo-seq to obtain a genome-wide gene expression profile with a high spatial resolution throughout the mammalian heart after ischemic injury. Cardiac ischemia reperfusion damage induces a heterogeneous remodeling response that involves several key processes, such as cardiac fibrosis, cardiomyocyte hypertrophy, and a change in calcium handling within the heart muscle cells. 2, 3, 13, 14 Localized expressional differences of well-known marker genes for these remodeling processes allowed us to uncover novel genes that showed a comparable transcriptional regulation and are linked to specific aspects of cardiac remodeling. Using this dataset, we identified SOX9 as a key transcriptional regulator of ECM-related genes and showed that in vivo loss of Sox9 after myocardial infarction blunted the cardiac fibrotic response on ischemic injury.
Although RNA sequencing techniques on tissue samples have been instrumental in defining genes relevant for cardiac remodeling and repair, 4,5 so far these approaches have been disadvantaged by the fact that the signals are derived from tissue homogenates, which inherently causes the loss of spatial information and dilutes out more localized expression signatures. In addition, conventional methods for defining localized changes in genes expression, such as ISH or immunohistochemistry, are limited to a defined set of candidate genes and do not allow for genome-wide screening for novel relevant gene candidates. Recent developments in RNA amplification strategies provide the opportunity to use small amounts of input RNA for genome-wide sequencing, as exemplified by tomoseq. 6 Although recent studies showed this method to provide insightful data for the developing and injured zebrafish heart, 6, 19 our study shows for the first time the relevance for the mammalian heart after ischemic injury. Especially the transcriptional differences, introduced by the localized heterogeneity in remodeling throughout an individual infarcted heart, appeared to be valuable for the identification of clusters of genes that showed a comparable regulation in expression. For this study, we focused on genes that showed an equivalent transcriptional regulation pattern across the infarcted tissue as well-known functions in fibrosis, cardiomyocyte hypertrophy, or contractility (Col1a2, Nppa, or Serca2). 2, 3, 13, 14 Based on subsequent functional annotation analysis, expressional confirmation in human ischemic tissue samples, and functional in vitro and in vivo assays, we conclude that the high spatial resolution in gene expression signatures obtained by tomo-seq allows for the identification of new relevant factors for specific aspects of heart disease. While we were preparing our manuscript, it was also reported that Fstl1, 1 of our top Col1a2-coregulated genes, is important for cardiac fibroblast activation, 20 which further underscores the relevance of our approach for identifying new players in specific cardiac remodeling responses.
Using our tomo-seq data, we identified SOX9 as common transcription factor able to regulate the expression of the majority of the Col1a2-coregulated genes. SOX9 is a transcription factor essential for chrondrogenesis by the activation of many ECM genes. 21 In the heart, SOX9 is highly expressed during development, where it promotes epithelial-to-mesenchymal transition and ECM organization during heart valve development. 22, 23 In the adult heart, SOX9 has been shown to play a role in valve calcification. 24, 25 Although SOX9 has been implicated in the fibrotic response of the liver, 15 so far it was unknown to play a role in cardiac fibrosis. We show that SOX9 is induced in response to ischemic injury and that in vivo loss of SOX9 after myocardial infarction blunts the cardiac fibrotic response on damage, revealing a previously unknown function for SOX9 in cardiac fibrosis. In addition, we show that SOX9 is mainly active in the fibroblast population that repopulates the infarcted area after injury.
In our efficacy studies, we make use of a reduction in SOX9 levels instead of complete deletion, which is sufficient to cause an effect on cardiac fibrosis after injury. An equally profound phenotype in the heart has been reported by others on heterozygous deletion of Rock1 and Klf6, 2 other key regulators of fibrosis. 26, 27 This finding suggests that the molecular mechanisms that drive cardiac fibrosis are sensitive to small perturbations in gene expression. Because therapeutically targeting of SOX9 would also moderately lower expression levels, we think this genetic model offers a good representation of what would happen when using an inhibitor of SOX9 in the clinic as a therapy for cardiac fibrosis.
Here we show that the high spatial resolution in gene expression signatures obtained by tomo-seq reveals new regulators, genetic pathways, and transcription factors that are active in well-defined regions of the heart and potentially involved in specific aspects of heart disease. This knowledge increases our mechanistic insights into cardiac remodeling and function and will help guide the identification of novel therapeutic candidates. However, the applicability of this approach is far greater than ischemic heart disease and the remodeling aspects we now focused on, and it can serve to identify new relevant factors for many different biological processes and disease states.
